
    
      Through the collection of outcomes data, Lung Institute aims to explore and describe the
      safety and efficacy of autologous stem cell treatment for chronic lung disease with
      dissemination to the public and to the medical community for the advancement of regenerative
      medicine. The study aims to confirm the safety of autologous cell therapy, explore the effect
      of autologous cell therapy treatment on pulmonary function over time, and to describe the
      anecdotal quality of life changes of patients following treatment using quantitative and
      qualitative measures.
    
  